Federal Supply Schedule 36F79718D0524

Award Date 8/1/18
Last Date to Order 7/31/28
Ultimate Awardee
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
This indefinite delivery contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, has a ceiling value of $2,000,000 and an ultimate completion date of April 30, 2028. Under this contract, Veracyte will provide reference laboratory services, including specialized genomic testing and classifier services, to support...
The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
The key products and services being delivered under this federal contract IDV award are specialized genomic testing services, primarily focused on prostate cancer diagnostics and treatment planning. The prime contractor, Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., provides its proprietary Decipher Prostate Cancer Test and other advanced molecular diagnostic capabilities to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Networks (VISNs)...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the provision of Decipher Prostate Cancer Testing services. This contract, valued at up to $991,815.95, is established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not have a set-aside designation. The contract aims to support the VA's efforts to provide personalized,...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 8 awarded a $972,177 Blanket Purchase Agreement (BPA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., to provide Decipher Prostate Cancer genomic testing services. This single-award IDV contract, utilizing the GSA Medical Laboratory Testing and Analysis Services Schedule, enables VISN 8 facilities to efficiently access Decipher's proprietary molecular diagnostic tests to support...
This federal contract IDV is a Federal Supply Schedule (FSS) award to Guardant Health, Inc. for medical laboratory testing and analysis services, specifically the Guardant360 assay. The contract, valued at up to $700,000, was awarded by the U.S. Department of Veterans Affairs (VA) and runs from September 2020 through August 2025. The Guardant360 assay evaluates blood samples for genomic alterations associated with solid tumor therapy selection using next-generation sequencing of cell-free DNA....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery, indefinite quantity contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., with a potential value of $249,000.00 and a period of performance through September 30, 2023. Against this contract, the agency issued four firm fixed price delivery orders for prostate cancer testing services. The orders called for providing the proprietary...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a single-award Blanket Purchase Agreement to Decipher Biosciences, Inc., operating under Veracyte Labs SD Corp, against the Medical Laboratory Testing and Analysis Services schedule. The BPA call provides for prostate testing services in the amount of $390,000 to be performed over an 11-month period in San Diego, California. Specifically, the contractor will deliver Decipher Prostate...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Genomind Inc. The contract, valued at up to $225,000.00, is for 621 II, MEDICAL LABORATORY TESTING & ANALYSIS SERVICES and has a period of performance through May 31, 2030. As an FSS contract, this is a multiple award vehicle that allows the VA and other federal agencies to procure these medical laboratory testing and analysis services. The contract does not...

The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing Classifier for thyroid nodules, Envisia Genomic Classifier for interstitial lung diseases, and Percepta Genomic Sequencing Classifier for lung cancer risk stratification. Delivery orders issued under this IDV, ranging from $38,784 to $484,800, task Veracyte with performing these specialized genomic testing services at its facilities in South San Francisco, California and Miami, Florida to support the VA's cancer detection efforts for veterans. The contract does not have any set-aside designations, allowing Veracyte, a for-profit organization, to provide these genomic testing services to federal agencies on a firm fixed price basis.

Veracyte also holds a separate $600,000 Indefinite Delivery Indefinite Quantity (IDIQ) contract with the VA's Veterans Integrated Service Network 23 to provide a broader range of reference laboratory services. This enables VISN 23 hospitals and clinics to efficiently access Veracyte's commercial laboratory capabilities to supplement their internal diagnostic testing capacity for veterans in northern and central California. The testing services delivered under both the GSA Schedule and VISN 23 IDIQ contracts are intended to aid in clinical diagnosis and treatment planning for federal government patients.

Generated 4/6/25, 12:47 AM